Company intelligence / Profile preview

Rapha Pharmaceuticals, Inc.

Orlando, Florida, United Statesraphapharma.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Rapha Pharmaceuticals has developed and commercialized products such as the Morning After® Levonorgestrel Tablet for emergency contraception. The company also specializes in custom and compounded drug formulations, including GLP‑1 peptides and other hormonals. Their R&D focuses on novel therapies for neglected or unmet medical needs in areas like women’s health, sleep, pain, and sexual health[1].

Therapeutic areas: Infectious DiseasesNeurologyWomen's Health
Modalities: Small moleculesPeptides (including GLP-1)Hormonal therapiesSterile injectablesSolid dose medications[1]
Industry: Biotech

Drug pipeline

2 assets

levonorgestrel

Commercial

Indications: Emergency contraception

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Rapha Pharmaceuticals, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rapha Pharmaceuticals, Inc..

Explore the full profile